We investigated the role of carbon monoxide as a neural modulator of extracellular glutamate concen tration in rat hippocampus CAl in transient forebrain ischemia by using metalloporphyrins, which block the production of carbon monoxide through the inhibition of heme oxygenase (HO) activity. Infusion of 10 and 100 fLM zinc protoporphyrin IX, which inhibits nitric oxide syn thase activity as well as HO activity, significantly in creased glutamate concentration compared with that on
Like nitric oxide (NO), carbon monoxide (CO), which is also a noxious gas that activates guanylyl cyclase, is a candidate neural messenger (Verma et aI., 1993; Dawson and Snyder, 1994) . Heme ring cleavage by heme oxygenase (HO) generates CO and biliverdin, which is rapidly reduced to bilirubin (Sun et aI. , 1990) . Blocking of CO production with zinc protoporphyrin IX (Zn PP-9), an HO inhibitor, prevents the induction of long-term potentiation (LTP) in hippocampal slices (Stevens and Wang, 1993; Zhuo et aI. , 1993) , blocks the effect of me tabotropic glutamate receptor activation in rat brain slices (Glaum and Miller, 1993) , inhibits release of corticotropin-releasing hormone in cell culture (Parkes et aI. , 1994; Pozzoli et aI. , 1994) , and re duces depolarization-induced glutamate release in synaptoneurosomes (Shinomura et aI. , 1994) . Al though these in vitro studies indicate that CO may the vehicle-treated side. However, infusion of 100 fLM tin mesoporphyrin IX, which inhibits only HO activity, did not affect glutamate concentration in ischemia. Our re sults therefore do not support the hypothesis that carbon monoxide acts as a neural messenger through the modu lation of extracellular glutamate concentration in isch emia. Key Words: Carbon monoxide-Forebrain isch emia-Glutamate-Heme oxygenase-Neural modula tor-Nitric oxide.
act as a neural messenger, no in vivo studies have examined the role of CO in cerebral ischemia. Fur thermore, Meffert et al. (1994) reported that Zn PP-9 inhibits not only HO, but also NO synthase (NOS) activity, while tin mesoporphyrin IX (Sn MP-9) inhibits HO activity with little effect on NOS activity. Therefore, previous data concerning the role of CO, obtained by using Zn PP-9, may reflect the inhibitory effects on both HO and NOS activi ties. To test the hypothesis that CO acts as a neural messenger modulating extracellular glutamate con centration in ischemia, we evaluated the effects of infusing Zn PP-9 and Sn MP-9 in the hippocampus CA l on glutamate concentration in rats with tran sient forebrain ischemia, using an in vivo brain mi crodialysis technique. We also evaluated the effect of infusing bilirubin, an end product of heme catab olism that acts as an antioxidant (Sto(; ker et aI. , 1987a,b) .
MATERIALS AND METHODS
Male Wistar rats weighing -350 g were used. Transient forebrain ischemia was achieved by using a modification of the four-vessel occlusion method (Pulsinelli and Bri erly, 1979; Schmidt-Kastner et aI., 1989) . On day 1, fol-lowing anesthesia with 2.5% halothane, both vertebral arteries were permanently occluded by electrocautery. Two microdialysis probe/platinum electrode assemblies (EPT-BDP-I-2-0 1; Eicom, Kyoto, Japan) were placed ste reotaxically at the CAl region of the hippocampus bilat erally (bregma, 3.6 mm; lateral, 2.2 mm; depth, 2.8 mm). Simultaneously, a thermocouple probe (52K/J thermom eter; John Fluke Mfg., W A, U.S.A.) was placed in the subdural space through a burr hole. On day 2, rats were reanesthetized with 2.5% halothane for insertion of a fem oral arterial catheter and a venous catheter. Each rat was then tracheotomized, paralyzed with pancuronium bro mide (0.6 mg/kg i.v.), and ventilated with a mixture of 30% oxygen, 70% nitrous oxide, and 1.0% halothane. Both carotid arteries were transiently occluded with mi croaneurysm clips for 30 min. Animals that did not show flattened EEG at the ischemic insult were excluded from the study. During the experiment, brain and rectal tem peratures were controlled at � 3rC with an external heat ing lamp and a heating pad, respectively. Arterial gases, blood glucose, and hematocrit were examined during the experiment. At the end of the experiment, animals were killed with an overdose of pentobarbital sodium.
In all rats, both microdialysis probes were perfused with Ringer's solution (155 mM NaCI, 5.5 mM KCI, 2.3 mM CaCI2) starting 2.5 h prior to carotid occlusion at a rate of 2.0 f.l.l/min. Animals were divided into four groups as follows: Group 1 (n = 7), group 2 (n = 8), and group 4 (n = 7) received 10 and 100 f.l.M Zn PP-9 (Paesel, Frank furt, Germany) and 100 f.l.M Sn MP-9 (Porphyrin Prod ucts, UT, U.S.A.), respectively, dissolved in Ringer's so lution with 1.0% polyoxyethylene sorbitan monooleate (pH 7.0) (Wako, Tokyo, Japan) in the left hippocampus and Ringer's solution with 1.0% polyoxyethylene sorbi tan monooleate as the control in the right hippocampus. Group 3 (n = 6) received 100 f.l.M Zn PP-9 dissolved in the same solution as for group 1 in the left hippocampus and 100 f.l.M Zn PP-9 with 100 f.l.M bilirubin (Wako) in the opposite hippocampus. The infusions were started 0.5 h prior to the occlusion and stopped at 1 h postocclusion.
Glutamate concentration in the dialysates was mea sured by HPLC with fluorescence detection after precol umn derivatization with o-phthaldialdehyde (Lindroth and Mopper, 1979) . The glutamate response was cali brated with internal and external standards. CBF was measured by the hydrogen clearance method (Aukland et al., 1964) using a digital blood flow meter (NMG-D 1; Unique Medical, Tokyo, Japan).
The statistical significance of differences in glutamate concentration and CBF between with and without treat ment before ischemia and in glutamate concentration and CBF between both hippocampi in each group was ana lyzed by the one-sample Wilcoxon test.
RESULTS
Although statistically significant changes in phys iological parameters in each group were observed (the paired t test), these changes were within the ranges of normal physiologic responses in forebrain ischemia and were thought unlikely to have materi ally affected the conclusions reached about the drugs used.
The changes in CBF in hippocampal CAl are given in Table 1 . Preischemia CBF in the four groups ranged from 76.2 to 87.5 ml 100 g -I min -I, and a statistically significant difference was ob served between the two hippocampi in group 1 only. Before the onset of ischemia, no treatment in any of the four groups changed the CBF value sig nificantly. During ischemia and recirculation, no significant difference in CBF values between the two hippocampi in any group was observed. Thus, there was no significant difference in CBF values at preischemia, during ischemia, or during recircula tion among the four groups.
Before onset of ischemia, there was no significant difference in extracellular glutamate levels between the two hippocampi in any group. None of the treat ments changed the extracellular glutamate level be fore ischemia compared with that in Ringer's solu tion in each group. In group 1, topical infusion of 10 fJ-M Zn PP-9 significantly increased glutamate con centration, which reached 2,497 ± 1,649 and 2,738 ± 2,444% of baseline compared with 1,255 ± 1,123 and 1,296 ± 1,142% of baseline at the 30-min isch emia and 10-min recirculation time points in the ve hicle-treated side, respectively (p < 0.05, one sample Wilcoxon test). In group 2 ( Fig. la) , topical All values are means ± SD. In preischemia, the microdialysis probes in both hippocampi in all groups were perfused with Ringer's solution alone. After preischemia, the microdialysis probe in each hippocampus was perfused with the designated solutions described in the text. PP, protoporhyrin; MP. mesoporphyrin. infusion of 100 J-LM Zn PP-9 also significantly in creased glutamate concentration at the 30-min isch emia and 10-min recirculation time points compared with the vehicle-treated side (p < 0.05, one-sample Wilcoxon test). In group 3, there was no significant difference in glutamate concentration between the side treated with 100 J-LM Zn PP-9 and the other treated with 100 J-LM Zn PP-9 and 100 J-LM bilirubin.
In group 4 ( Fig. 1 b) , glutamate concentrations in the vehicle-treated side and the 100 J-LM Sn MP-9treated side reached 1,226 ± 838 and 1,050 ± 493% of baseline at the IO-min recirculation time point, respectively, and no significant difference in gluta mate concentration between the two sides was ob served.
DISCUSSION
A role of CO as a neural messenger has been proposed (Verma et aI., 1993; Dawson and Snyder, 1994) , but its influence in cerebral ischemia has not been studied. Our main finding is that the adminis tration of Sn MP-9 does not affect extracellular glu tamate concentration during forebrain ischemia, while the administration of Zn PP-9 significantly in creases glutamate concentration during ischemia and following recirculation. Since Zn PP-9 reduces NOS activity in a dose-dependent fashion, while Sn MP-9 has no significant effect on NOS activity (Meffert et aI., 1994) , we assume that our data using Zn PP-9 may reflect inhibition of NOS activity in addition to inhibition ofHO activity. Thus, our find ing that Sn MP-9 had no effect on glutamate con centration is not consistent with the hypothesis that CO acts as a neural messenger modulating extracel lular glutamate concentration in ischemia. This con firms the work of Meffert et al. (1994) , who have concluded that CO does not act as a mediator in either LTP induction or expression/maintenance, because the ability of metalloporphyrins to block L TP in rat hippocampal slices was better correlated with their inhibition of NOS than with their inhibi tion of HO, which basically coincides with our con clusion.
Although it is generally accepted that neuronal NO production contributes to the development of Schema showin g the proposed relation between ex tracellular g lutamate and CO in cerebral ischemia. Excessive accumulation of extracellular g lutamate in cerebral ischemia may increase intracellular Ca2+ throu g h the activation of g lu tamate receptors. NO is involved as a neural messen g er by modulatin g extracellular g lutamate concentration in cerebral ischemia (*). Althou g h the mechanism of the activation of heme oxy g enase (HO) in ischemia is unclear, HO cleaves the heme rin g into CO and biliverdin. Biliverdin is rapidly re duced to bilirubin. Zinc protoporphyrin IX (Zn PP-9) inhibits both HO and NO synthase activities, while tin mesoporphyrin IX (Sn MP-9) inhibits only HO activity. Sn MP-9 did not affect g lutamate concentration in ischemia in this study. A dotted arrow indicates the inhibitory effect by the dru g . ischemic brain injury (H uang et a!., 1994) , the effect of NOS inhibitors on glutamate concentration in ischemia is still controversial. In focal ischemia, it was found that an NOS inhibitor suppressed the increase in extracellular glutamate (Buisson et a!., 1993) . In forebrain ischemia, however, an NOS in hibitor increased extracellular glutamate concentra tion during ischemia (Nanri et a!., 1994) or on reper fusion (Zhang et a!., 1993 (Zhang et a!., , 1995 , although the mechanism involved is unclear. Therefore, our find ing of an increase in glutamate concentration by Zn PP-9 in forebrain ischemia may reflect the inhibi tory effect on NOS activity. To examine other pos sible explanations for this result, we evaluated the effect of bilirubin on extracellular glutamate in isch emia, because bilirubin, which is also suppressed by Zn PP-9, can efficiently scavenge peroxyl radi cals at micromolar concentrations in vitro (Stocker et aI., 1987a,b) . Our results suggested that the glu tamate increase caused by Zn PP-9 was not related to suppression of bilirubin production. Further, Zn PP-9 had no influence on CBF. Thus, the effect of Zn PP-9 seems to arise predominantly through its modification of NOS levels. We present a schema showing the proposed relation between extracellu lar glutamate and CO in cerebral ischemia in Fig. 2 .
In conclusion, our data do not support a role of CO in the modulation of extracellular glutamate concentration, although the possibility remains that CO may have other functions as a neural messenger in the brain.
